Eblasakimab monotherapy improves moderate-to-severe atopic dermatitis symptoms across anatomical regions in a Phase 1 study
Karen A. Veverka, Josemund Menezes, Steven Tien Guan Thng
1st International Societies for Investigative Dermatology Meeting, May 2023